08/04/2025
6:04 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/04/2025
6:09 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2025
8:03 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2025
3:45 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2025
5:41 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
5:42 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
4:44 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
4:45 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2025
8:01 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
5:14 PM | JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
5:18 PM | Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KRYS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. |
06/30/2025
5:23 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
4:59 PM | Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
5:04 PM | Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
5:09 PM | Krystal Biotech (Issuer)
Mason Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
4:12 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:08 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
7:09 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:53 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
3:44 PM | Krystal Biotech (Filer)
| Form ARS | |
04/03/2025
3:38 PM | Krystal Biotech (Filer)
| Form DEF 14A | |
03/13/2025
5:04 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
5:06 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
5:58 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
6:00 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
6:01 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
10:52 AM | Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
6:19 AM | Krystal Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
6:25 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
6:51 AM | Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
12/18/2024
7:39 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:27 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
5:28 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:22 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2024
7:30 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:00 PM | Krystal Biotech (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/04/2024
7:04 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
7:05 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2024
11:28 AM | Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
09/13/2024
4:41 PM | Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:44 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) So, unless you’ve been living under a rock, you probably saw the news…
Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯
We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. 🎯 Click here to watch the video and get the free ticker XGPT just flagged. |
09/13/2024
4:45 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:33 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:33 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:31 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access